LM-061 / LaNova Medicines Limited  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LM-061 / LaNova Medicines Limited
NCT04737122: Study of LM-061 in Subjects in Advanced Tumors

Terminated
1
18
RoW
LM-061, Kinase inhibitor, Toripalimab
LaNova Medicines Limited
Advanced Tumours
07/22
12/22

Download Options